Pharmaceutical Therapy for Osteoarthritis

被引：43
作者：
Cheng, David S. [2 ]
Visco, Christopher J. [1 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Rehabil & Regenerat Med, New York, NY 10032 USA
[2] NYU, Dept Anesthesiol, Langone Med Ctr, New York, NY 10016 USA
来源：
PM&R | 2012年 / 4卷 / 05期
关键词：
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TOPICAL DICLOFENAC SOLUTION; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL COMPLICATIONS; NITRIC-OXIDE; CHRONIC PAIN; ACETAMINOPHEN; MANAGEMENT;
D O I：
10.1016/j.pmrj.2012.02.009
中图分类号：
R49 [康复医学];
学科分类号：
100215 ;
摘要：
There are a variety of oral and topical pharmaceutical agents for the treatment of osteoarthritis. To date there is no pharmacologic agent proved to prevent disease progression. This article focuses primarily on the medications used for symptomatic relief and palliation of pain. The article reviews the medications' mechanisms of action and the available efficacy literature, as well as indications, contraindications, and common adverse effects. PM R 2012;4:S82-588
引用
收藏
页码：S82 / S88
页数：7
相关论文
共 71 条
[1]   Nitric oxide in inflammation and pain associated with osteoarthritis [J].
Abramson, Steven B. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (Suppl 2)
[2]  
Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905
[3]  
[Anonymous], 2002, Cochrane Database Syst Rev, DOI 10.1002/14651858.CD002296
[4]   Acetaminophen and adverse chronic renal outcomes: An appraisal of the epidemiologic evidence [J].
Barrett, BJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :S14-S19
[5]   Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: A randomized controlled trial [J].
Beaulieu, Andre D. ;
Peloso, Paul M. ;
Haraoui, Boulos ;
Bensen, William ;
Thomson, Glen ;
Wade, John ;
Quigley, Patricia ;
Eisenhoffer, John ;
Harsanyi, Zoltan ;
Darke, Andrew C. .
PAIN RESEARCH & MANAGEMENT, 2008, 13 (02) :103-110
[6]   SPONTANEOUS CARTILAGE DEGENERATION IN GUINEA-PIGS [J].
BENDELE, AM ;
HULMAN, JF .
ARTHRITIS AND RHEUMATISM, 1988, 31 (04) :561-565
[7]   Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial [J].
Bensen, WG ;
Fiechtner, JJ ;
McMillen, JI ;
Zhao, WW ;
Yu, SS ;
Woods, EM ;
Hubbard, RC ;
Isakson, PC ;
Verburg, KM ;
Geis, GS .
MAYO CLINIC PROCEEDINGS, 1999, 74 (11) :1095-1105
[8]  
Benson Gordon D, 2005, Am J Ther, V12, P133, DOI 10.1097/01.mjt.0000140216.40700.95
[9]   Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee - Results of the two-year multinational knee osteoarthritis structural arthritis study [J].
Bingham, Clifton O., III ;
Buckland-Wright, J. Chris ;
Garnero, Patrick ;
Cohen, Stanley B. ;
DougadoS, Maxime ;
Adarni, Silvano ;
Clauw, Daniel J. ;
Spector, Timothy D. ;
Pelletier, Jean-Pierre ;
Raynauld, Jean-Pierre ;
Strand, Vibeke ;
Simon, Lee S. ;
Meyer, Joan M. ;
Cline, Gary A. ;
Beary, John F. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3494-3507
[10]  
BJORKMAN R, 1995, ACTA ANAESTH SCAND, V39, P3
12345678